Toshima Z. Parris

ORCID: 0000-0003-0834-5540
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • BRCA gene mutations in cancer
  • Breast Cancer Treatment Studies
  • Cancer-related Molecular Pathways
  • Effects of Radiation Exposure
  • Cancer Genomics and Diagnostics
  • Radiopharmaceutical Chemistry and Applications
  • Gene expression and cancer classification
  • Molecular Biology Techniques and Applications
  • Ubiquitin and proteasome pathways
  • Genomic variations and chromosomal abnormalities
  • HER2/EGFR in Cancer Research
  • Ferroptosis and cancer prognosis
  • Thyroid Cancer Diagnosis and Treatment
  • Ovarian cancer diagnosis and treatment
  • Epigenetics and DNA Methylation
  • Breast Lesions and Carcinomas
  • Neuroendocrine Tumor Research Advances
  • Radiation Therapy and Dosimetry
  • Genomics and Chromatin Dynamics
  • Cancer Cells and Metastasis
  • Neuroblastoma Research and Treatments
  • Cancer-related molecular mechanisms research
  • Genetic factors in colorectal cancer
  • Medical Imaging Techniques and Applications
  • Peptidase Inhibition and Analysis

Sahlgrenska University Hospital
2014-2025

University of Gothenburg
2015-2025

Institute of Clinical Research
2023

University of Oxford
2013

Hunter College
1999

Marine Biological Laboratory
1999

Breast cancer is a potentially fatal malignancy in females despite the improvement therapeutic techniques. The identification of novel molecular signatures needed for earlier detection, monitoring effects treatment, and predicting prognosis. We have previously used microarray analysis to identify differentially expressed genes aggressive breast tumors. purpose present study was investigate prognostic value candidate biomarkers CCNB2, ASPM, CDCA7, KIAA0101, SLC27A2 cancer. expression levels...

10.1186/1471-2407-13-1 article EN cc-by BMC Cancer 2013-01-02

Abstract Cancer drug development has been riddled with high attrition rates, in part, due to poor reproducibility of preclinical models for discovery. Poor experimental design and lack scientific transparency may cause biases that turn affect data quality, robustness reproducibility. Here, we pinpoint sources variability conventional 2D cell-based cancer screens determine the effect confounders on cell viability MCF7 HCC38 breast lines treated platinum agents (cisplatin carboplatin) a...

10.1038/s41598-020-62848-5 article EN cc-by Scientific Reports 2020-04-02

The BIRC5 gene encodes for the Survivin protein, which is a member of inhibitor apoptosis family. found in humans during fetal development, but generally not adult cells thereafter. Previous studies have shown that abundant most cancer cells, thereby making it promising target anti-cancer drugs and potential prognostic tool.To assess genetic alterations mutations as well co-expression with other genes, genomic transcriptomic data were downloaded via cBioPortal approximately 9000 samples from...

10.1186/s12885-022-09371-0 article EN cc-by BMC Cancer 2022-03-25

To evaluate the prognostic significance of changes in pre- and post-neoadjuvant chemotherapy (NACT) Ki67 patients with primary invasive triple-negative breast cancer (TNBC). Population-based registry data were retrieved for diagnosed TNBC between 2007 2021 (n = 9262). Multivariable Cox regression analysis was performed disease-specific survival (DSS) overall (OS) adjusted age residual disease nodes (RDBN). Of 1777 receiving NACT, 54 achieved pathologic complete response (pCR) 755 had...

10.1007/s10549-025-07610-z article EN cc-by Breast Cancer Research and Treatment 2025-01-12

Deregulation of key cellular pathways is fundamental for the survival and expansion neoplastic cells. In cancer, regulation gene transcription can be mediated in a variety ways. The purpose this study was to assess impact dosage on expression patterns effect other mechanisms transcriptional levels, associate these genomic changes with clinicopathologic parameters.We screened 97 invasive diploid breast tumors DNA copy number alterations levels using array comparative hybridization...

10.1158/1078-0432.ccr-10-0889 article EN Clinical Cancer Research 2010-06-16

Genetic and epigenetic (DNA methylation, histone modifications, microRNA expression) crosstalk promotes inactivation of tumor suppressor genes or activation oncogenes by gene loss/hypermethylation duplications/hypomethylation, respectively. The 8p11-p12 chromosomal region is a hotspot for genomic aberrations (chromosomal rearrangements, amplifications deletions) in several cancer forms, including breast carcinoma where amplification has been associated with increased proliferation rates...

10.1038/oncsis.2014.8 article EN cc-by Oncogenesis 2014-03-24

Abstract Triple-negative breast cancer (TNBC) is associated with poor prognosis and limited treatment options due to the lack of important receptors (estrogen receptor [ER], progesterone [PR], human epidermal growth factor 2 [HER2]) used for targeted therapy. However, high-throughput in vitro drug screening cell lines a powerful tool identifying effective drugs disease. Here, we determine intrinsic chemosensitivity TNBC proteasome inhibitors (PIs), thereby potentially potent 2-drug...

10.1038/s41420-024-01819-5 article EN cc-by Cell Death Discovery 2024-01-29

The deregulation of key cellular pathways is fundamental for the survival and expansion neoplastic cells, which in turn can have a detrimental effect on patient outcome. To develop effective individualized cancer therapies, we need to better understanding are perturbed genetically defined subgroup patients. Here, validate prognostic value 13‐marker signature independent gene expression microarray datasets ( n = 1,141) immunohistochemistry with full‐faced FFPE samples 71). predictive...

10.1002/ijc.28497 article EN International Journal of Cancer 2013-10-12

In cancer radiotherapy, knowledge of normal tissue responses and toxicity risks is essential in order to deliver the highest possible absorbed dose tumor while maintaining exposure at non-critical levels. However, few studies have investigated vivo after (211)At administration. identify molecular biomarkers ionizing radiation exposure, we genome-wide transcriptional (very) low mean doses from mouse tissues.Female BALB/c nude mice were intravenously injected with 1.7 kBq killed 1 h, 6 or 7...

10.1186/s13550-014-0078-7 article EN cc-by EJNMMI Research 2015-01-27

Abstract Background Ovarian cancer is the main cause of gynecological cancer-associated death. However, 5-year survival rates differ dramatically between five ovarian carcinoma histotypes. Therefore, we need to have a better understanding mechanisms that promote histotype-specific carcinogenesis and identify novel prognostic biomarkers. Methods Here, evaluated role 29 genes for early-stage (I II) carcinomas ( n = 206) using immunohistochemistry (IHC). Results We provide evidence aberrant...

10.1186/s12885-019-6084-4 article EN cc-by BMC Cancer 2019-09-18

Breast cancer (BC) histological and molecular classifications significantly improved the treatment strategy prognosis. Inhibitor of apoptosis BIRC5/survivin is often overexpressed in cancers, however, indications its importance BC are inconsistent. We integrate BIRC5 protein mRNA measures with clinical associates long-term outcome three independent cohorts Protein levels were measured primary lysates 845 patients West Swedish cohort (VGR-BC) linked to 5- 27-years survival. The results...

10.3390/cancers13092209 article EN Cancers 2021-05-04

This study explores the role of titin, a giant muscle protein, in progression epithelial ovarian cancer (EOC). We examined titin levels tissues and sera from EOC patients across stages I-IV chemoresistant cells. Tissue samples underwent immunohistochemistry, serum were measured using ELISA. Quantitative real-time PCR analyzed mRNA cell lines, including chemosensitive, chemoresistant, normal Notably, elevated detected 90.9% stage I compared to only 14.3% III IV tissues. Serum consistently...

10.1016/j.omton.2025.200932 article EN cc-by Deleted Journal 2025-01-14

Squamous cell carcinoma of the oral cavity (OSCC) is a common cancer form with relatively low 5-year survival rates, due partially to late detection and lack complementary molecular markers as targets for treatment. Molecular profiling head neck has revealed biological similarities basal-like breast lung carcinoma. Recently, we showed that 16 genes were consistently altered in invasive tumors displaying varying degrees aggressiveness. To extend our findings from another type similar...

10.1186/1471-2407-14-324 article EN cc-by BMC Cancer 2014-05-07

Abstract Neuro-inflammation and neuronal communication are considered as mis-regulated processes in the aetiology pathology of bipolar disorder (BD). Which when specific signal pathways become abnormal during ontogeny patients is unknown. To address this question, we applied induced pluripotent stem cell (iPSC) technology followed by cortical neural differentiation on adipocyte-derived cells from BD type I (with psychotic episodes psychiatric history) healthy volunteers (controls). RNA...

10.1038/tp.2016.284 article EN cc-by Translational Psychiatry 2017-01-24

Early-stage (I and II) ovarian carcinoma patients generally have good prognosis. Yet, some die earlier than expected. Thus, it is important to stratify early-stage into risk groups identify those in need of more aggressive treatment regimens. The prognostic value 29 histotype-specific biomarkers identified using RNA sequencing was evaluated for clear-cell (CCC), endometrioid (EC) mucinous (MC) carcinomas (n = 112) immunohistochemistry on tissue microarrays. Biomarkers with significance were...

10.3389/fonc.2020.00162 article EN cc-by Frontiers in Oncology 2020-02-18

Previous studies have shown that the ADIPOR1, ADORA1, BTG2 and CD46 genes differ significantly between long-term survivors of breast cancer deceased patients, both in levels gene expression DNA copy numbers. The aim this study was to characterize corresponding proteins carcinoma determine their correlation with clinical outcome. Protein evaluated using immunohistochemistry an independent cohort 144 samples represented on tissue microarrays. Fisher's exact test used analyze differences...

10.1186/1471-2407-10-296 article EN cc-by BMC Cancer 2010-06-16

Astatine-211 (211At) is an alpha particle emitting halogen with almost optimal linear energy transfer for creating DNA double-strand breaks and thus proposed radionuclide therapy when bound to tumor-seeking agents. Unbound 211At accumulates in the thyroid gland, concept of basal radiation-induced biological effects tissue is, a high degree, unknown most valuable. Female BALB/c nude mice were intravenously injected 0.064 42 kBq 211At, resulting absorbed doses 0.05 32 Gy gland. Thyroids...

10.1186/2191-219x-2-32 article EN cc-by EJNMMI Research 2012-01-01

(211)At is a promising therapeutic radionuclide because of the nearly optimal biological effectiveness emitted α-particles. Unbound accumulates in thyroid gland and other vital normal tissues. However, few studies have been performed that assess (211)At-induced normal-tissue damage vivo. Knowledge about extent quality resulting responses various organs offers new venue for reducing risks side effects increasing overall well-being patient during after therapy.Female BALB/c nude mice were...

10.2967/jnumed.112.114462 article EN Journal of Nuclear Medicine 2013-05-08

The aim of this study was to investigate the global gene expression response normal tissues following internal low absorbed dose irradiation 131I.Balb/c mice were intravenously injected with 13 260 kBq 131I and euthanized 24 h after injection. Kidneys, liver, lungs, spleen surgically removed. 0.1 9.7 mGy. Total RNA extracted, Illumina MouseRef-8 Whole-Genome Expression BeadChips (Illumina, Inc., San Diego, California, USA) used compare irradiated that non-irradiated controls....

10.1186/2191-219x-1-29 article EN cc-by EJNMMI Research 2011-01-01

177Lu-octreotate can be used to treat somatostatin receptor expressing neuroendocrine tumors. It is highly effective in animal models, but clinical studies have so far only demonstrated low cure rates. Hedgehog inhibitors shown therapeutic effect as monotherapy tumor model systems and might one option enhance the efficacy of therapy. The aim this study was determine combination therapy using signaling pathway inhibitor sonidegib. GOT1-bearing BALB/c nude mice were treated with either...

10.1186/s12885-017-3524-x article EN cc-by BMC Cancer 2017-08-08

Abstract The human nuclear receptor (NR) superfamily comprises 48 ligand-dependent transcription factors that play regulatory roles in physiology and pathophysiology. In cancer, NRs have long served as predictors of disease stratification, treatment response, clinical outcome. Cancer Genome Atlas (TCGA) Pan-Cancer project provides a wealth genetic data for large number cancer types. Here, we examined NR transcriptional activity 8,526 patient samples from 33 TCGA ‘Pan-Cancer’ diseases 11...

10.1038/s41598-020-58842-6 article EN cc-by Scientific Reports 2020-02-05

Triple-negative breast cancer (TNBC) is an aggressive form of associated with poor survival, in which adjuvant systemic treatments are limited to chemotherapy. Due competing mortality risks and comorbidities, older patients TNBC often undertreated chemotherapy, clinical trials on this problem scarce, despite a growing patient population. This study aimed assess outcomes for aged 70 years or without chemotherapy national population-based registry, provide information that can assist treatment...

10.1016/s2666-7568(20)30018-0 article EN cc-by The Lancet Healthy Longevity 2020-11-30

Abstract Identification of causative genetic variants leading to the development bipolar disorder (BD) could result in tests that would facilitate diagnosis. A better understanding affected genes and pathways is also necessary for targeting may improve treatment strategies. To date several susceptibility have been reported from genome-wide association studies (GWAS), but little known about specific affect disease development. Here, we performed quantitative proteomics whole-genome sequencing...

10.1038/s41398-020-01056-1 article EN cc-by Translational Psychiatry 2020-11-09

Background: Triple-negative breast cancer (TNBC) is an aggressive subtype with the most unfavorable clinical outcomes, in part due to tumor heterogeneity, treatment resistance, and relapse. The TNBC subtypes [basal-like 1 (BL1), basal-like 2 (BL2), mesenchymal (M), luminal androgen receptor (LAR)] are biologically clinically distinct entities that respond differently local systemic therapies. Therefore, we need have a better understanding of stemness relating drug-resistant populations...

10.3389/fcell.2023.1237673 article EN cc-by Frontiers in Cell and Developmental Biology 2023-09-12

Abstract Mutation analysis is typically performed at the DNA level since most technical approaches are developed for analysis. However, some applications, like transcriptional mutagenesis, RNA editing and gene expression analysis, require Here, we combine reverse transcription digital sequencing to enable low error sequencing. We evaluate yield, reproducibility, dynamic range correction rate seven different conditions using multiplexed assays. The reproducibility vary substantially between...

10.1038/s42003-024-05955-7 article EN cc-by Communications Biology 2024-03-01
Coming Soon ...